Search research articles
Contact Us
Filters
Showing results (141-150 of 221) with videos related to
Page
of 23
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Flavone acetic acid: a nonlinear pharmacokinetic model
A Gouyette, D J Kerr, S B Kaye, et al.
British Journal of Clinical Pharmacology
|
October 1, 1985
The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum
D J Kerr, J Graham, R G Blackie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1996
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?
A M Cohen, N E Kemeny, C H Köhne, et al.
Oncogene
|
October 5, 1995
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2
A G Eliopoulos, D J Kerr, J Herod, et al.
British Journal of Cancer
|
October 1, 1990
Long-term sequelae of treatment for testicular germ cell tumours
D Bissett, L Kunkeler, L Zwanenburg, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
The effect of verapamil on the pharmacokinetics of adriamycin
D J Kerr, J Graham, J Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1996
A pilot study of combination therapy with interferon-alpha-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours
M J Hughes, D J Kerr, J Cassidy, et al.
British Journal of Cancer
|
February 1, 1991
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour
J A Goldberg, T Murray, D J Kerr, et al.
EXS
|
January 1, 1992
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs
D J Kerr, J A Goldberg, J R Anderson, et al.
British Journal of Cancer
|
November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer
D J Kerr, G J Rustin, S B Kaye, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 221) with videos related to
Sort By:
Page
of 23
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Flavone acetic acid: a nonlinear pharmacokinetic model
A Gouyette, D J Kerr, S B Kaye, et al.
British Journal of Clinical Pharmacology
|
October 1, 1985
The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum
D J Kerr, J Graham, R G Blackie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1996
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?
A M Cohen, N E Kemeny, C H Köhne, et al.
Oncogene
|
October 5, 1995
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2
A G Eliopoulos, D J Kerr, J Herod, et al.
British Journal of Cancer
|
October 1, 1990
Long-term sequelae of treatment for testicular germ cell tumours
D Bissett, L Kunkeler, L Zwanenburg, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
The effect of verapamil on the pharmacokinetics of adriamycin
D J Kerr, J Graham, J Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1996
A pilot study of combination therapy with interferon-alpha-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours
M J Hughes, D J Kerr, J Cassidy, et al.
British Journal of Cancer
|
February 1, 1991
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour
J A Goldberg, T Murray, D J Kerr, et al.
EXS
|
January 1, 1992
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs
D J Kerr, J A Goldberg, J R Anderson, et al.
British Journal of Cancer
|
November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer
D J Kerr, G J Rustin, S B Kaye, et al.
Page
of 23